Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

High Frequencies of Mutated EZH2 and IRF8 and Other Epigenetic Genes in Primary Bone Lymphomas Are Indicative of GCB-Phenotype

Blood (2019) 134 (Supplement_1): 1484.

https://doi.org/10.1182/blood-2019-129832

Published: 2019

Journal Articles

A Novel Prognostic Model Based on Tumor Microenvironment Biology in Relapse Biopsies Predicts Post-Autologous Stem Cell Transplantation Outcomes in Classical Hodgkin Lymphoma

Fong Chun Chan, Anja Mottok, Alina S Gerrie, MD, Maryse M Power, MD, Kerry J Savage, MD, Marcel Nijland, MD, Arjan Diepstra, MD PhD, Anke Van den Berg, PhD, Joseph M. Connors, Randy D. Gascoyne, Sohrab P. Shah, David W. Scott, Christian Steidl

Blood (2016) 128 (22): 1093.

https://doi.org/10.1182/blood.V128.22.1093.1093

Published: 2016

Journal Articles

Mir-155 Enhances B-Cell Lymphoma Growth By Targeting TBRG1

Joost Kluiver, PhD, Izabella Slezak-Prochazka, PhD, Melanie Winkle, Lydia Visser, PhD, Arjan Diepstra, MD PhD, Bart-Jan Kroesen, PhD, Anke Van den Berg, PhD

Blood (2015) 126 (23): 4820.

https://doi.org/10.1182/blood.V126.23.4820.4820

Published: 2015

Journal Articles

Mutations in CD58 and Other Immune System Related Genes in Hodgkin Lymphoma

Fazlyn Reeny Abdul Razak, Arjan Diepstra, MD PhD, Lydia Visser, PhD, Anke Van den Berg, PhD

Blood (2015) 126 (23): 1439.

https://doi.org/10.1182/blood.V126.23.1439.1439

Published: 2015

Journal Articles

Impact of Radiotherapy and Rituximab on Outcome of Stage I(E) Diffuse Large B-Cell Lymphoma

Marcel Nijland, MD, Karin Boslooper, MD, Anke Van den Berg, PhD, Hanneke C. Kluin-Nelemans, MD PhD, Peter Joosten, MD, Huib Storm, MD PhD, Robby Kibbelaar, MD PhD, Gustaaf van Imhoff, MD PhD, Mels Hoogendoorn, MD PhD

Blood (2015) 126 (23): 1503.

https://doi.org/10.1182/blood.V126.23.1503.1503

Published: 2015

Journal Articles

Meta-Analysis of Hodgkin Lymphoma and Asthma Genome-Wide Association Scans reveals common variants in GATA3

Blood (2014) 124 (21): 135.

https://doi.org/10.1182/blood.V124.21.135.135

Published: 2014

Journal Articles

Specific PML Isoforms and SATB1 Affect HLA Expression In Classical Hodgkin Lymphoma

Yuxuan Liu, Anke Van Den Berg, PhD, Bea Rutgers, Rianne Veenstra, Debora de Jong, Gertrud Kortman, Gustaaf van Imhoff, Lydia Visser, Arjan Diepstra, MD PhD

Blood (2013) 122 (21): 4234.

https://doi.org/10.1182/blood.V122.21.4234.4234

Published: 2013

Journal Articles

A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc

Wendy Cozen, D.O., M.P.H., Dalin Li, M.D., Ph.D., Maria Timofeeva, Ph.D., Arjan Diepstra, MD PhD, Dennis Hazelett, Ph.D., Manon Delahaye-Sourdeix, M.S., Christopher K. Edlund, M.S., Klaus Rostgaard, Ph.D., David J. Van Den Berg, Ph.D., Lude Franke, Ph.D., Karin Eckstrom Smedby, M.D., Ph.D., Sally L. Glaser, Ph.D., Harm-Jam Westra, Ph.D., Leslie L. Robison, PhD, Thomas M. Mack, M.D., M.P.H., Herve Ghesquieres, MD, PhD, Amie E. Hwang, Ph.D., M.P.H., Alexandra Nieters, Ph.D., Silvia de Sanjosé, M.D., Ph.D., Victoria K. Cortessis, Ph.D., Tracy Lightfoot, Nikolaus Becker, M.D., Ph.D., Marc Maynadie, MD, PhD, Lenka Foretova, Ph.D., Eve Roman, Ph.D., Yolanda Benavente, Ph.D., Bharat N. Nathwani, M.D., Bengt Glimelius, M.D., Ph.D., Anthony Staines, M.D., Ph.D., Paolo Boffetta, M.D., M.P.H., Brian K Link, MD, L. A. Kiemeney, Ph.D., Stephen M Ansell, M.D.Ph.D., Smita Bhatia, Ph.D., Louise C Strong, Ph.D., Pilar Galan, M.D., Lars Vatten, M.D., Ph.D., Thomas M Habermann, MD, Eric J. Duell, Ph.D., M.S., Annette Lake, M.S., Rianne Veenstra, Lydia Visser, PhD, Kevin Urayama, Ph.D., Dorothy Montgomery, Valerie Gaborieau, Lawrence Weiss, M.D, Graham Byrnes, Ph.D., Mark Lathrop, PhD, Hans-Olov Adami, M.D., Ph.D., Mads Melbye, MD, DMSc, James R Cerhan, MD, PhD, Alice Gallagher, M.D., G. Malcolm Taylor, MD, Susan L Slager, PhD, Paul Brennan, Ph.D., David V. Conti, Ph.D., Gerhard Coetzee, Ph.D., Kenan Onel, MD, PhD, Ruth F. Jarrett, M.D., Ph.D., Henrik Hjalgrim, M.D., Ph.D., Anke Van Den Berg, PhD, James D. McKay, Ph.D.

Blood (2013) 122 (21): 626.

https://doi.org/10.1182/blood.V122.21.626.626

Published: 2013

Journal Articles

HLA Associated Susceptibility to EBV+ Hodgkin Lymphoma: No Correlation with Infectious Mononucleosis or Number of Circulating EBV+ B Cells.

Arjan Diepstra, MD PhD, Alison M Leese, Annette Pachnio, PhD, Andrew I Bell, PhD, Bouke Hepkema, PhD, Anke Van Den Berg, PhD, Paul AH Moss, MD PhD, Steven P Lee, PhD, Alan B Rickinson, PhD

Blood (2012) 120 (21): 2635.

https://doi.org/10.1182/blood.V120.21.2635.2635

Published: 2012

Journal Articles

Expression, Prognostic Value and Function of IGF1R in Hodgkin Lymphoma.

Zheng Liang, MD, Arjan Diepstra, MD PhD, Chuanhui Xu, MD PhD, Gustaaf W van Imhoff, MD, PhD, Wouter J Plattel, MD, Anke Van Den Berg, PhD, Lydia Visser, PhD

Blood (2012) 120 (21): 2640.

https://doi.org/10.1182/blood.V120.21.2640.2640

Published: 2012

Journal Articles

Strong HLA Class I Expression Is Positively Correlated with the Number of PML Nuclear Bodies and Negatively with the Percentage of SATB1 Positive HRS Cells in EBV+ Classical Hodgkin Lymphoma (cHL)

Yuxuan Liu, Lydia Visser, Rianne Veenstra, Bea Rutgers, Anke Van Den Berg, PhD, Arjan Diepstra, MD PhD

Blood (2012) 120 (21): 3633.

https://doi.org/10.1182/blood.V120.21.3633.3633

Published: 2012

Journal Articles

EBV and HLA Associations In Classical Hodgkin Lymphoma Patients From Brazil

Kushi Kushekhar, Rianne Veenstra, Gabriela Gualco, Pollyanna Domeney, MD, Bouke Hepkema, PhD, Lydia Visser, PhD, Carlos E Bacchi, MD, Arjan Diepstra, MD, PhD, Anke Van Den Berg, PhD

Blood (2011) 118 (21): 4858.

https://doi.org/10.1182/blood.V118.21.4858.4858

Published: 2011

Journal Articles

CCR4 Expression in Hodgkin Lymphoma

Lydia Visser, Myrna van West, Bea Rutgers, Sibrand Poppema, Anke Van Den Berg, PhD

Blood (2011) 118 (21): 2626.

https://doi.org/10.1182/blood.V118.21.2626.2626

Published: 2011

Journal Articles

CSF1R Expression of Hodgkin Reed Sternberg Cells Is Associated with the Number of Macrophages in the Tumor Microenvironment and Is Correlated with Treatment Outcome

Christian Steidl, MD, Arjan Diepstra, MD, PhD, Tang Lee, M.Sc., Pedro Farinha, MD, Adele Telenius, M.Sc., Merrill Boyle, B.Sc., Sohrab P Shah, PhD, Lorena Barclay, Anke Van Den Berg, PhD, Kerry J. Savage, MD MSc, Joseph M. Connors, MD, Randy D. Gascoyne, MD

Blood (2011) 118 (21): 427.

https://doi.org/10.1182/blood.V118.21.427.427

Published: 2011

Journal Articles

HLA Class I and EBV Positive Classical Hodgkin Lymphoma In the Chinese Population

Huang Xin, MD, Arjan Diepstra, MD, PhD, Zifen Gao, MD, PhD, Lydia Visser, PhD, Hans Vos, Wierd Kooistra, Sibrand Poppema, MD, PhD, Bouke Hepkema, PhD, Anke Van Den Berg, PhD

Blood (2010) 116 (21): 2688.

https://doi.org/10.1182/blood.V116.21.2688.2688

Published: 2010

Journal Articles

Expression of the c-Met Oncogene Correlates with Favorable Progression Free Survival In Classical Hodgkin Lymphoma

Chuanhui Xu, Anke Van Den Berg, PhD, Wouter Plattel, drs., Nele Ruther, Huang Xin, Sr, Miao Wang, Gustaaf Van Imhoff, MD, PhD, Andreas Viardot, Peter Möller, Sibrand Poppema, MD, PhD, Lydia Visser, PhD

Blood (2010) 116 (21): 3880.

https://doi.org/10.1182/blood.V116.21.3880.3880

Published: 2010

Journal Articles

Mid-Treatment Plasma Levels of Thymus Activated and Regulated Chemokine (TARC) Predict Treatment Outcome In Classical Hodgkin Lymphoma Patients

Wouter Plattel, MD, Anke Van Den Berg, PhD, Anne Marijn Van der Graaf, Hans Vos, Lydia Visser, PhD, Arjan Diepstra, MD, PhD, Gustaaf van Imhoff, MD, PhD

Blood (2010) 116 (21): 748.

https://doi.org/10.1182/blood.V116.21.748.748

Published: 2010

Journal Articles

Protective and Predisposing HLA Alleles In Dutch Classical Hodgkin Lymphoma Patients

Arjan Diepstra, MD, PhD, Xin Huang, Ilja Nolte, PhD, Bouke Hepkema, PhD, Wierd Kooistra, Lydia Visser, PhD, Sibrand Poppema, MD, PhD, Anke Van Den Berg, PhD

Blood (2010) 116 (21): 749.

https://doi.org/10.1182/blood.V116.21.749.749

Published: 2010

Journal Articles

Contribution of Deregulated miRNAs to the Phenotypic Characteristic of Hodgkin Lymphoma.

Lu Ping Tan, BSc,MSc, Bart-Jan Kroesen, PhD, Enrico Tiacci, PhD, Gerben Duns, Erwin Seinen, Ody Sibon, PhD, Klaas Kok, PhD, Sibrand Poppema, MD, PhD, Anke Van Den Berg, PhD

Blood (2009) 114 (22): 265.

https://doi.org/10.1182/blood.V114.22.265.265

Published: 2009

Journal Articles

The HGF/c-Met Signaling Pathway in Hodgkin Lymphoma.

Chuanhui Xu, Anke Van Den Berg, PhD, Arjan Diepstra, Miao Wang, Debora Jong, Hans JTWM Vos, Peter Moller, MD, Sibrand Poppema, MD, PhD, Lydia Visser

Blood (2009) 114 (22): 1551.

https://doi.org/10.1182/blood.V114.22.1551.1551

Published: 2009

NARROW

High Frequencies of Mutated EZH2 and IRF8 and Other Epigenetic Genes in Primary Bone Lymphomas Are Indicative of GCB-Phenotype

A Novel Prognostic Model Based on Tumor Microenvironment Biology in Relapse Biopsies Predicts Post-Autologous Stem Cell Transplantation Outcomes in Classical Hodgkin Lymphoma

Mir-155 Enhances B-Cell Lymphoma Growth By Targeting TBRG1

Mutations in CD58 and Other Immune System Related Genes in Hodgkin Lymphoma

Impact of Radiotherapy and Rituximab on Outcome of Stage I(E) Diffuse Large B-Cell Lymphoma

Meta-Analysis of Hodgkin Lymphoma and Asthma Genome-Wide Association Scans reveals common variants in GATA3

Specific PML Isoforms and SATB1 Affect HLA Expression In Classical Hodgkin Lymphoma

A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc

HLA Associated Susceptibility to EBV+ Hodgkin Lymphoma: No Correlation with Infectious Mononucleosis or Number of Circulating EBV+ B Cells.

Expression, Prognostic Value and Function of IGF1R in Hodgkin Lymphoma.

Strong HLA Class I Expression Is Positively Correlated with the Number of PML Nuclear Bodies and Negatively with the Percentage of SATB1 Positive HRS Cells in EBV+ Classical Hodgkin Lymphoma (cHL)

EBV and HLA Associations In Classical Hodgkin Lymphoma Patients From Brazil

CCR4 Expression in Hodgkin Lymphoma

CSF1R Expression of Hodgkin Reed Sternberg Cells Is Associated with the Number of Macrophages in the Tumor Microenvironment and Is Correlated with Treatment Outcome

HLA Class I and EBV Positive Classical Hodgkin Lymphoma In the Chinese Population

Expression of the c-Met Oncogene Correlates with Favorable Progression Free Survival In Classical Hodgkin Lymphoma

Mid-Treatment Plasma Levels of Thymus Activated and Regulated Chemokine (TARC) Predict Treatment Outcome In Classical Hodgkin Lymphoma Patients

Protective and Predisposing HLA Alleles In Dutch Classical Hodgkin Lymphoma Patients

Contribution of Deregulated miRNAs to the Phenotypic Characteristic of Hodgkin Lymphoma.

The HGF/c-Met Signaling Pathway in Hodgkin Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only